United States · FDA National Drug Code directory

DALFAMPRIDINE

Source ingredient · 11 source records

Names are grouped within this source and country. A shared ingredient does not establish interchangeable medicines.

United States · Source reference 0259-5010_b0f65c2b-ee14-421f-9f24-178e108e38cf

AMPYRA

TABLET, FILM COATED, EXTENDED RELEASE / Merz Pharmaceuticals, LLC

United States · Source reference 10144-427_dda9045d-2f23-412c-9543-74832f421739

AMPYRA

TABLET, FILM COATED, EXTENDED RELEASE / Merz Pharmaceuticals, LLC

United States · Source reference 42571-275_3afc3c42-1157-b612-e063-6294a90ac179

DALFAMPRIDINE

TABLET, EXTENDED RELEASE / Micro Labs Limited

United States · Source reference 65862-863_8a071f78-8849-495d-ad29-832d5f250a19

DALFAMPRIDINE

TABLET, FILM COATED, EXTENDED RELEASE / Aurobindo Pharma Limited

United States · Source reference 72162-2459_fd48fc9a-fe75-4178-806c-ea935728cc7f

DALFAMPRIDINE

TABLET, EXTENDED RELEASE / Bryant Ranch Prepack

United States · Source reference 0591-2533_f2d33c82-a69f-4f6a-bd74-2c91efd6cab8

Dalfampridine

TABLET, FILM COATED, EXTENDED RELEASE / Actavis Pharma, Inc.

United States · Source reference 16729-292_40bc3607-8ee1-5a56-e063-6294a90a3b3b

Dalfampridine

TABLET, FILM COATED, EXTENDED RELEASE / Accord Healthcare Inc.

United States · Source reference 51407-876_57b465fb-f201-a156-e063-6394a90abc28

Dalfampridine

TABLET, FILM COATED, EXTENDED RELEASE / Golden State Medical Supply, Inc.

United States · Source reference 62756-429_c3c3b8ae-9dac-40fc-8569-b26d6befbf01

Dalfampridine

TABLET, EXTENDED RELEASE / Sun Pharmaceutical Industries, Inc.

United States · Source reference 67877-444_7359109d-e6d1-4e42-bb3b-746e8d5fb686

Dalfampridine

TABLET, FILM COATED, EXTENDED RELEASE / Ascend Laboratories, LLC

United States · Source reference 82249-702_c40dcc84-b839-44aa-94f2-886fb1c3d75c

Dalfampridine

TABLET, FILM COATED, EXTENDED RELEASE / CivicaScript LLC

Browse ingredients in United States →